Preformulation Study of Carbamazepine Orally Disintegrating Tablets for Pediatric Patients Using Direct Compression and the SeDeM Diagram Tool: A Quality by Design Approach

<b>Background/Objectives:</b> Carbamazepine is widely used as a first-line treatment for pediatric patients with benign epilepsy. However, most commercial formulations have doses of 100 mg or higher, limiting their suitability for pediatric use. The aim of this study was to develop mini...

Full description

Saved in:
Bibliographic Details
Main Authors: Ricard Canadell-Heredia, Khadija Rouaz-El-Hajoui, Natalia Franco-Piedrahita, Pilar Pérez-Lozano, Marc Suñé-Pou, Josep María Suñé-Negre, Encarna García-Montoya
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/17/5/624
Tags: Add Tag
No Tags, Be the first to tag this record!